241 related articles for article (PubMed ID: 26560698)
1. Tumor progression locus 2 ablation suppressed hepatocellular carcinoma development by inhibiting hepatic inflammation and steatosis in mice.
Li X; Liu C; Ip BC; Hu KQ; Smith DE; Greenberg AS; Wang XD
J Exp Clin Cancer Res; 2015 Nov; 34():138. PubMed ID: 26560698
[TBL] [Abstract][Full Text] [Related]
2. Tumor progression locus 2 (TPL2) regulates obesity-associated inflammation and insulin resistance.
Perfield JW; Lee Y; Shulman GI; Samuel VT; Jurczak MJ; Chang E; Xie C; Tsichlis PN; Obin MS; Greenberg AS
Diabetes; 2011 Apr; 60(4):1168-76. PubMed ID: 21346175
[TBL] [Abstract][Full Text] [Related]
3. High-refined-carbohydrate and high-fat diets induce comparable hepatic tumorigenesis in male mice.
Ip BC; Liu C; Smith DE; Ausman LM; Wang XD
J Nutr; 2014 May; 144(5):647-53. PubMed ID: 24647392
[TBL] [Abstract][Full Text] [Related]
4. Tumor Progression Locus 2 in Hepatocytes Potentiates Both Liver and Systemic Metabolic Disorders in Mice.
Gong J; Fang C; Zhang P; Wang PX; Qiu Y; Shen LJ; Zhang L; Zhu XY; Tian S; Li F; Wang Z; Huang Z; Wang A; Zhang XD; She ZG
Hepatology; 2019 Feb; 69(2):524-544. PubMed ID: 29381809
[TBL] [Abstract][Full Text] [Related]
5. SCD1 Expression is dispensable for hepatocarcinogenesis induced by AKT and Ras oncogenes in mice.
Li L; Wang C; Calvisi DF; Evert M; Pilo MG; Jiang L; Yuneva M; Chen X
PLoS One; 2013; 8(9):e75104. PubMed ID: 24069385
[TBL] [Abstract][Full Text] [Related]
6. Tpl2 kinase regulates inflammation but not tumorigenesis in mice.
Wu KC; Cain G; Corpuz J; Xu D; Ljumanovic N; Zarrin AA
Toxicol Appl Pharmacol; 2021 May; 418():115494. PubMed ID: 33722668
[TBL] [Abstract][Full Text] [Related]
7. Rosuvastatin as a potential preventive drug for the development of hepatocellular carcinoma associated with non-alcoholic fatty liver disease in mice.
Yokohama K; Fukunishi S; Ii M; Nakamura K; Ohama H; Tsuchimoto Y; Asai A; Tsuda Y; Higuchi K
Int J Mol Med; 2016 Nov; 38(5):1499-1506. PubMed ID: 28025996
[TBL] [Abstract][Full Text] [Related]
8. Tumor progression locus 2/Cot is required for activation of extracellular regulated kinase in liver injury and toll-like receptor-induced TIMP-1 gene transcription in hepatic stellate cells in mice.
Perugorria MJ; Murphy LB; Fullard N; Chakraborty JB; Vyrla D; Wilson CL; Oakley F; Mann J; Mann DA
Hepatology; 2013 Mar; 57(3):1238-49. PubMed ID: 23080298
[TBL] [Abstract][Full Text] [Related]
9. Interleukin-17 induces AP-1 activity and cellular transformation via upregulation of tumor progression locus 2 activity.
Kim G; Khanal P; Lim SC; Yun HJ; Ahn SG; Ki SH; Choi HS
Carcinogenesis; 2013 Feb; 34(2):341-50. PubMed ID: 23125217
[TBL] [Abstract][Full Text] [Related]
10. Gp78, an E3 ubiquitin ligase acts as a gatekeeper suppressing nonalcoholic steatohepatitis (NASH) and liver cancer.
Zhang T; Kho DH; Wang Y; Harazono Y; Nakajima K; Xie Y; Raz A
PLoS One; 2015; 10(3):e0118448. PubMed ID: 25789613
[TBL] [Abstract][Full Text] [Related]
11. TPL2 Is a Key Regulator of Intestinal Inflammation in Clostridium difficile Infection.
Wang Y; Wang S; Kelly CP; Feng H; Greenberg A; Sun X
Infect Immun; 2018 Aug; 86(8):. PubMed ID: 29844241
[TBL] [Abstract][Full Text] [Related]
12. Deletion of tumor progression locus 2 attenuates alcohol-induced hepatic inflammation.
Stice CP; Hussain S; Liu C; Ausman LM; Wang XD; Greenberg AS
Hepatobiliary Surg Nutr; 2016 Feb; 5(1):29-37. PubMed ID: 26904554
[TBL] [Abstract][Full Text] [Related]
13. Metformin delays AKT/c-Met-driven hepatocarcinogenesis by regulating signaling pathways for de novo lipogenesis and ATP generation.
Zhang C; Hu J; Sheng L; Yuan M; Wu Y; Chen L; Zheng G; Qiu Z
Toxicol Appl Pharmacol; 2019 Feb; 365():51-60. PubMed ID: 30625338
[TBL] [Abstract][Full Text] [Related]
14. Tumor progression locus 2 (TPL2) in tumor-promoting Inflammation, Tumorigenesis and Tumor Immunity.
Njunge LW; Estania AP; Guo Y; Liu W; Yang L
Theranostics; 2020; 10(18):8343-8364. PubMed ID: 32724474
[TBL] [Abstract][Full Text] [Related]
15. Tpl2 Ablation Leads to Hypercytokinemia and Excessive Cellular Infiltration to the Lungs During Late Stages of Influenza Infection.
Latha K; Jamison KF; Watford WT
Front Immunol; 2021; 12():738490. PubMed ID: 34691044
[TBL] [Abstract][Full Text] [Related]
16. Immunopositivity for histone macroH2A1 isoforms marks steatosis-associated hepatocellular carcinoma.
Rappa F; Greco A; Podrini C; Cappello F; Foti M; Bourgoin L; Peyrou M; Marino A; Scibetta N; Williams R; Mazzoccoli G; Federici M; Pazienza V; Vinciguerra M
PLoS One; 2013; 8(1):e54458. PubMed ID: 23372727
[TBL] [Abstract][Full Text] [Related]
17. Tumor progression locus-2 is a critical regulator of pancreatic and lung inflammation during acute pancreatitis.
Van Acker GJ; Perides G; Weiss ER; Das S; Tsichlis PN; Steer ML
J Biol Chem; 2007 Jul; 282(30):22140-9. PubMed ID: 17537724
[TBL] [Abstract][Full Text] [Related]
18. Sterile inflammation in acetaminophen-induced liver injury is mediated by Cot/tpl2.
Sanz-Garcia C; Ferrer-Mayorga G; González-Rodríguez Á; Valverde AM; Martín-Duce A; Velasco-Martín JP; Regadera J; Fernández M; Alemany S
J Biol Chem; 2013 May; 288(21):15342-51. PubMed ID: 23572518
[TBL] [Abstract][Full Text] [Related]
19. Tpl2 kinase impacts tumor growth and metastasis of clear cell renal cell carcinoma.
Lee HW; Joo KM; Lim JE; Cho HJ; Cho HJ; Park MC; Seol HJ; Seo SI; Lee JI; Kim S; Jeong BC; Nam DH
Mol Cancer Res; 2013 Nov; 11(11):1375-86. PubMed ID: 23982215
[TBL] [Abstract][Full Text] [Related]
20. Tumor progression locus 2 (Map3k8) is critical for host defense against Listeria monocytogenes and IL-1 beta production.
Mielke LA; Elkins KL; Wei L; Starr R; Tsichlis PN; O'Shea JJ; Watford WT
J Immunol; 2009 Dec; 183(12):7984-93. PubMed ID: 19933865
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
